These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
450 related items for PubMed ID: 23708322
1. The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial. Colazingari S, Treglia M, Najjar R, Bevilacqua A. Arch Gynecol Obstet; 2013 Dec; 288(6):1405-11. PubMed ID: 23708322 [Abstract] [Full Text] [Related]
2. The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome. Dinicola S, Chiu TT, Unfer V, Carlomagno G, Bizzarri M. J Clin Pharmacol; 2014 Oct; 54(10):1079-92. PubMed ID: 25042908 [Abstract] [Full Text] [Related]
3. Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome. Pacchiarotti A, Carlomagno G, Antonini G, Pacchiarotti A. Gynecol Endocrinol; 2016 Oct; 32(1):69-73. PubMed ID: 26507336 [Abstract] [Full Text] [Related]
4. The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone. Nordio M, Proietti E. Eur Rev Med Pharmacol Sci; 2012 May; 16(5):575-81. PubMed ID: 22774396 [Abstract] [Full Text] [Related]
5. High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial. Mendoza N, Galan MI, Molina C, Mendoza-Tesarik R, Conde C, Mazheika M, Diaz-Ropero MP, Fonolla J, Tesarik J, Olivares M. Gynecol Endocrinol; 2020 May; 36(5):398-401. PubMed ID: 31657275 [Abstract] [Full Text] [Related]
6. Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature. Regidor PA, Schindler AE, Lesoine B, Druckman R. Horm Mol Biol Clin Investig; 2018 Mar 02; 34(2):. PubMed ID: 29498933 [Abstract] [Full Text] [Related]
12. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Papaleo E, Unfer V, Baillargeon JP, Fusi F, Occhi F, De Santis L. Fertil Steril; 2009 May 02; 91(5):1750-4. PubMed ID: 18462730 [Abstract] [Full Text] [Related]
13. Inositol: history of an effective therapy for Polycystic Ovary Syndrome. Bizzarri M, Carlomagno G. Eur Rev Med Pharmacol Sci; 2014 Jul 02; 18(13):1896-903. PubMed ID: 25010620 [Abstract] [Full Text] [Related]
14. Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients. Monastra G, Unfer V, Harrath AH, Bizzarri M. Gynecol Endocrinol; 2017 Jan 02; 33(1):1-9. PubMed ID: 27898267 [Abstract] [Full Text] [Related]
15. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis. Zhao H, Xing C, Zhang J, He B. Reprod Health; 2021 Aug 18; 18(1):171. PubMed ID: 34407851 [Abstract] [Full Text] [Related]
18. Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials. Mendoza N, Pérez L, Simoncini T, Genazzani A. Reprod Biomed Online; 2017 Nov 18; 35(5):529-535. PubMed ID: 28756130 [Abstract] [Full Text] [Related]